| Dr Jeffrey J Sandhaus, MD | |
|
3601 31st Ave, Astoria, NY 11106-1051 | |
| (718) 932-3535 | |
| (718) 932-6939 |
| Full Name | Dr Jeffrey J Sandhaus |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 3601 31st Ave, Astoria, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558341305 | NPI | - | NPPES |
| 00169228 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 0991021 (New York) | Primary |
| Entity Name | North Shore Medical Group Of The Mount Sinai School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275640609 PECOS PAC ID: 8921999087 Enrollment ID: O20040320000412 |
News Archive
Also in the news, reports estimate state-specific costs and savings related to the overhaul's Medicaid expansion.
A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.
As wearable fitness trackers become ever more popular and sophisticated, they provide new opportunities for monitoring training and guiding post-injury rehabilitation in endurance runners, according to an article in the December issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine (ACSM).
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.
› Verified 7 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477932275 PECOS PAC ID: 2264691070 Enrollment ID: O20150811003333 |
News Archive
Also in the news, reports estimate state-specific costs and savings related to the overhaul's Medicaid expansion.
A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.
As wearable fitness trackers become ever more popular and sophisticated, they provide new opportunities for monitoring training and guiding post-injury rehabilitation in endurance runners, according to an article in the December issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine (ACSM).
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey J Sandhaus, MD 3601 31st Ave, Astoria, NY 11106-1051 Ph: (718) 932-3535 | Dr Jeffrey J Sandhaus, MD 3601 31st Ave, Astoria, NY 11106-1051 Ph: (718) 932-3535 |
News Archive
Also in the news, reports estimate state-specific costs and savings related to the overhaul's Medicaid expansion.
A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.
As wearable fitness trackers become ever more popular and sophisticated, they provide new opportunities for monitoring training and guiding post-injury rehabilitation in endurance runners, according to an article in the December issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine (ACSM).
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.
› Verified 7 days ago
Dr. Steven M Tillem, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3119 Newtown Ave, Suite 801, Astoria, NY 11102 Phone: 718-777-2111 Fax: 718-732-2191 | |
Dr. Nikhil Waingankar, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2510 30th Ave, #a5-316, Astoria, NY 11102 Phone: 718-808-7876 |